Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
Clinic Significance:
1. NTRK1 (1Q21-Q22) encodes TRKA protein. When rearrangement occurs, it leads to abnormal cell proliferation. Trk inhibitors and crizotinib can reduce the phosphorylation of fusion protein and inhibit cell proliferation.
2. New therapeutic targets in lung adenocarcinoma.
NTRK1 Normal
NTRK1 Breakapart
Probe Description: NTRK1
Cat.No.: CF1015
Specification: 10 tests/box, 20 tests/box